Solid Biosciences Inc.SLDBNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank30
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P30
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-56.40%
2024-5.19%
20235.24%
2022-27.77%
2021-37.47%
202040.79%
2019-24.53%
2018-71.37%
2017-121.82%
2016-387.92%